BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19207420)

  • 1. Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.
    Stockman BJ; Kothe M; Kohls D; Weibley L; Connolly BJ; Sheils AL; Cao Q; Cheng AC; Yang L; Kamath AV; Ding YH; Charlton ME
    Chem Biol Drug Des; 2009 Feb; 73(2):179-88. PubMed ID: 19207420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a fluorescent ATP analog to probe the allosteric conformational change in the active site of the protein kinase PDK1.
    Hindie V; Lopez-Garcia LA; Biondi RM
    Methods Mol Biol; 2012; 928():133-41. PubMed ID: 22956138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
    Stroba A; Schaeffer F; Hindie V; Lopez-Garcia L; Adrian I; Fröhner W; Hartmann RW; Biondi RM; Engel M
    J Med Chem; 2009 Aug; 52(15):4683-93. PubMed ID: 19606904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
    Biondi RM; Nebreda AR
    Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design.
    Harris TK
    IUBMB Life; 2003 Mar; 55(3):117-26. PubMed ID: 12822887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept.
    Wilhelm A; Lopez-Garcia LA; Busschots K; Fröhner W; Maurer F; Boettcher S; Zhang H; Schulze JO; Biondi RM; Engel M
    J Med Chem; 2012 Nov; 55(22):9817-30. PubMed ID: 23106316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subcellular localization of 3-phosphoinositide-dependent protein kinase is controlled by caveolin-1 binding.
    Chun J; Kwon T; Lee EJ; Hyun S; Hong SK; Kang SS
    Biochem Biophys Res Commun; 2005 Jan; 326(1):136-46. PubMed ID: 15567163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1.
    Wei L; Gao X; Warne R; Hao X; Bussiere D; Gu XJ; Uno T; Liu Y
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3897-902. PubMed ID: 20627557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide-dependent kinase-1 orthologues from five eukaryotes are activated by the hydrophobic motif in AGC kinases.
    Silber J; Antal TL; Gammeltoft S; Rasmussen TE
    Biochem Biophys Res Commun; 2004 Sep; 321(4):823-7. PubMed ID: 15358101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
    Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
    Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA.
    Biondi RM; Cheung PC; Casamayor A; Deak M; Currie RA; Alessi DR
    EMBO J; 2000 Mar; 19(5):979-88. PubMed ID: 10698939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.
    Rettenmaier TJ; Sadowsky JD; Thomsen ND; Chen SC; Doak AK; Arkin MR; Wells JA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18590-5. PubMed ID: 25518860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.
    Biondi RM; Komander D; Thomas CC; Lizcano JM; Deak M; Alessi DR; van Aalten DM
    EMBO J; 2002 Aug; 21(16):4219-28. PubMed ID: 12169624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fused protein of deltaPKC activation loop and PDK1-interacting fragment (deltaAL-PIF) functions as a pseudosubstrate and an inhibitory molecule for PDK1 when expressed in cells.
    Seki T; Irie N; Nakamura K; Sakaue H; Ogawa W; Kasuga M; Yamamoto H; Ohmori S; Saito N; Sakai N
    Genes Cells; 2006 Sep; 11(9):1051-70. PubMed ID: 16923125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screening.
    Lee AC; Ramanujulu PM; Poulsen A; Williams M; Blanchard S; Ma DM; Bonday Z; Goh KL; Goh KC; Goh MK; Wood J; Dymock BW
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4023-7. PubMed ID: 22591730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1.
    Xu X; Chen Y; Fu Q; Ni D; Zhang J; Li X; Lu S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):361-374. PubMed ID: 30734603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of PDK1 kinase inhibitors with a novel mechanism of action by ultrahigh throughput screening.
    Bobkova EV; Weber MJ; Xu Z; Zhang YL; Jung J; Blume-Jensen P; Northrup A; Kunapuli P; Andersen JN; Kariv I
    J Biol Chem; 2010 Jun; 285(24):18838-46. PubMed ID: 20385558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
    Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning a protein kinase on or off from a single allosteric site via disulfide trapping.
    Sadowsky JD; Burlingame MA; Wolan DW; McClendon CL; Jacobson MP; Wells JA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6056-61. PubMed ID: 21430264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.
    Hindie V; Stroba A; Zhang H; Lopez-Garcia LA; Idrissova L; Zeuzem S; Hirschberg D; Schaeffer F; Jørgensen TJ; Engel M; Alzari PM; Biondi RM
    Nat Chem Biol; 2009 Oct; 5(10):758-64. PubMed ID: 19718043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.